Measuring human carboxylesterase 2 activity in pancreatic cancer patient-derived xenografts using a ratiometric fluorescent chemosensor
Open Access
- 29 July 2019
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Chemical Science
- Vol. 10 (36) , 8428-8437
Abstract
We report the development of a ratiometric fluorescent chemosensor that selectively measures human carboxylesterase 2 (hCES2) activity with application in pancreatic cancer patient-derived xenografts.Keywords
Funding Information
- Natural Sciences and Engineering Research Council of Canada (Discovery)
This publication has 40 references indexed in Scilit:
- The Role of Human Carboxylesterases in Drug Metabolism: Have We Overlooked Their Importance?Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013
- Examination of the carboxylesterase phenotype in human liverArchives of Biochemistry and Biophysics, 2012
- Prioritizing Phase I Treatment Options Through Preclinical Testing on Personalized TumorgraftJournal of Clinical Oncology, 2012
- Standards for photoluminescence quantum yield measurements in solution (IUPAC Technical Report)Pure and Applied Chemistry, 2011
- A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced CancerMolecular Cancer Therapeutics, 2011
- Characterization of Recombinant Human Carboxylesterases: Fluorescein Diacetate as a Probe Substrate for Human Carboxylesterase 2Drug Metabolism and Disposition, 2011
- Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient miceNature Protocols, 2009
- Age- and Sex-Related Expression and Activity of Carboxylesterase 1 and 2 in Mouse and Human LiverDrug Metabolism and Disposition, 2009
- Preclinical Efficacy of a Carboxylesterase 2-Activated Prodrug of DoxazolidineJournal of Medicinal Chemistry, 2009
- Identification of Human Intestinal Carboxylesterase as the Primary Enzyme for Activation of a Doxazolidine Carbamate ProdrugJournal of Medicinal Chemistry, 2008